GFS Advisors LLC lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 6.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 17,706 shares of the exchange traded fund’s stock after selling 1,251 shares during the period. GFS Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,595,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in XBI. Avior Wealth Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after buying an additional 307 shares during the period. Tidemark LLC lifted its stake in SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after acquiring an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. acquired a new position in SPDR S&P Biotech ETF during the 3rd quarter worth about $40,000. ORG Wealth Partners LLC purchased a new position in SPDR S&P Biotech ETF during the 3rd quarter valued at about $44,000. Finally, Howe & Rusling Inc. acquired a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at about $49,000.
SPDR S&P Biotech ETF Price Performance
Shares of NYSEARCA:XBI opened at $92.67 on Friday. The firm’s 50-day moving average is $93.24 and its two-hundred day moving average is $96.72. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The firm has a market capitalization of $7.06 billion, a PE ratio of 11.47 and a beta of 1.11.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Compound Interest and Why It Matters When Investing
- Nebius Group: Market Overreaction or Real AI Disruption?
- What is an Earnings Surprise?
- The Best Way to Invest in Gold Is…
- Growth Stocks: What They Are, Examples and How to Invest
- Why Nike Stock Could Be 2025’s Top Comeback Play
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.